Healthcare IT Today December 23, 2024
Clinically Validated, Scientifically Proven Fertility Decision-Support Platform to Serve More Families
FertilAI has raised $4.5 million co-led by Longevity Venture Partners and Redseed with additional investment from angel investors.
The company provides doctors with critical AI-driven patient insights to aid their clinical decision-making and optimize clinic workflow and efficiency, increasing daily treatments while maintaining the same level of high-quality care.
“The fertility market is growing at an unprecedented rate and becoming a pressing issue on a global scale,” said Raissa Hacohen, Managing Partner at Longevity Venture Partners. “We invested in FertilAI because the team’s expertise is uniquely suited to solve this market need and its platform has already demonstrated significant traction in the market.”
FertilAI focuses on making fertility treatments...
Today's Sponsors
Today's Sponsor